STOCK TITAN
  1. Home
  2. News
  3. CNMD

Conmed Corp. - CNMD STOCK NEWS

Welcome to our dedicated news page for Conmed (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on Conmed.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Conmed's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Conmed's position in the market.

News
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
Rhea-AI Summary
CONMED promoted Patrick Beyer to Chief Operating Officer, expanding his responsibilities to lead commercial businesses, operations, distribution, regulatory affairs, and customer excellence. Mr. Beyer's promotion reflects his track record of driving above-market growth and expanding the company's presence in key markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.58%
Tags
none
-
News
CONMED Corporation Announces First Quarter 2024 Financial Results
Rhea-AI Summary
CONMED reported strong financial results for the first quarter of 2024, with sales reaching $312.3 million, a 5.7% increase year-over-year. Domestic revenue saw a 7.2% growth, while international revenue increased by 3.8%. Diluted net earnings per share were $0.63 (GAAP) compared to $0.06 in Q1 2023, with adjusted diluted net earnings per share at $0.79, a 19.7% increase. The company expects reported revenue for the full year to be between $1.330 billion and $1.355 billion, with adjusted diluted net earnings per share projected in the range of $4.25 to $4.35.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.58%
Tags
earnings
-
News
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
Rhea-AI Summary
CONMED (CNMD) will release its first-quarter 2024 financial results on April 24, 2024, followed by a conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
earnings
News
CONMED Corporation Announces Quarterly Cash Dividend
Rhea-AI Summary
CONMED Corporation (CNMD) declares a quarterly cash dividend of $0.20 per share, payable on April 5, 2024, to shareholders of record as of March 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
dividends
-
News
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
Rhea-AI Summary
CONMED Corporation (CNMD) reported a 30.4% increase in sales for the fourth quarter of 2023 compared to the previous year, with domestic revenue up by 33.3%. International revenue also saw a significant increase. The company's full-year 2023 sales increased by 19.1% year over year, with both domestic and international revenues showing strong growth. Adjusted diluted net earnings per share for the fourth quarter of 2023 increased by 152.4% compared to the same period in 2022. The company expects continued growth in 2024, with a projected year-over-year revenue increase of 8% to 10% and adjusted diluted net earnings per share growth of 25% to 28%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.38%
Tags
earnings
-
News
CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024
Rhea-AI Summary
CONMED Corporation (CNMD) to report Q4 2023 financial results on January 31, 2024. Conference call scheduled for 4:30 p.m. ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
earnings
News
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
Rhea-AI Summary
CONMED Corporation (CNMD) to Present at J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
-
News
CONMED Corporation Announces Quarterly Cash Dividend
Rhea-AI Summary
CONMED Corporation (CNMD) declares a quarterly cash dividend of $0.20 per share, payable on January 5, 2024, to shareholders of record as of December 18, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
dividends
-
News
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) to Participate in Fireside Chat at Piper Sandler Healthcare Conference on November 28, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
conferences
News
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) will participate in fireside chats at two investor conferences in November. The first conference is the Stifel Healthcare Conference in New York, NY on November 14, 2023, where Curt R. Hartman and Eric Staves will be the speakers. The second conference is the Jefferies London Healthcare Conference in London, UK on November 15, 2023, where Todd W. Garner and Pat J. Beyer will be the speakers. The fireside chats will be accessible through the Company's website and will be available for replay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
Stock CNMD logo
Conmed Corp.

NYSE:CNMD

CNMD Rankings

#1864 Ranked by Market Cap
#947 Ranked by Stock Gains
#1728 Ranked by Dividends

CNMD Stock Data

2.30B
30.52M
0.54%
119.07%
13.2%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Utica

About CNMD

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500